Experimental Autoimmune Myasthenia Gravis in Rats
- 1 February 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 34 (2) , 75-79
- https://doi.org/10.1001/archneur.1977.00500140029004
Abstract
• In rats immunized with purified acetylcholine receptor protein (AChRP) fromTorpedoelectroplax, a defect of neuromuscular transmission physiologically identical to that seen in myasthenia gravis developed. The most sensitive index of the neuromuscular blockage was miniature end-plate potential (MEPP) amplitude. As early as 24 hours after inoculation with AChRP, the thymus showed reactive changes that are probably non-specific. Removal of the thymus before or within three days after immunization delayed, but did not prevent, development of reduced MEPP amplitude. Prednisolone given within 35 days after immunization produced reversal of MEPP reduction within 24 hours, but had no such immediate effect when given 15 days later. It is probable that prednisolone acted by reducing the immunologic responsiveness of the animals during the developing phase of the defect of neuromuscular transmission.This publication has 16 references indexed in Scilit:
- Long‐term administration of corticosteroids in myasthenia gravisNeurology, 1976
- END‐PLATE POTENTIALS IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS IN RATS*Annals of the New York Academy of Sciences, 1976
- Effect of prednisolone on neuromuscular blocking in mice in vivoNeurology, 1975
- Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs.The Journal of Experimental Medicine, 1975
- Purification and molecular properties of the acetylcholine receptor from Torpedo electroplaxArchives of Biochemistry and Biophysics, 1973
- Autoimmune Response to Acetylcholine ReceptorScience, 1973
- ROLE OF THE THYMUS IN TRANSPLANTATION IMMUNITY*Annals of the New York Academy of Sciences, 1962
- Effect of neonatal thymectomy on the immunological responsiveness of the mouseProceedings of the Royal Society of London. B. Biological Sciences, 1962
- Myasthenia Gravis: A New HypothesisScottish Medical Journal, 1960
- Changes in Serum Complement Activity in Patients with Myasthenia Gravis.Experimental Biology and Medicine, 1960